Ibex LTD Form 4 insider transactions

IBEX Ltd.'s Chief Financial Officer, Taylor C. Greenwald, acquired 4,196 common shares through performance-based units and subsequently sold 1,275 shares to cover tax obligations.

IBEX CEO Robert Thomas Dechant reported the acquisition of performance-based stock units and subsequent sale of shares to cover tax obligations.

IBEX Ltd's Chief Financial Officer, Taylor C Greenwald, sold 2,295 common shares at $40.7302 each to cover tax withholding obligations from restricted stock unit vesting.

IBEX Chief Sales/Marketing Officer Julie K Casteel sold 5,000 common shares on September 16, 2025, at $39.0002 per share, reducing her direct beneficial ownership to 25,895 shares.

IBEX Ltd's Chief Sales and CS Officer, Bruce Neil Dawson, sold 8,879 common shares on September 16, 2025, following an acquisition of 8,114 shares, all executed under a Rule 10b5-1 plan.

IBEX Ltd's CEO, Robert Thomas Dechant, executed a pre-planned transaction, exercising options for 45,027 common shares at $19 and subsequently selling them at $38.89.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported the sale of 844 common shares at $38.5 per share on September 16, 2025, executed under a Rule 10b5-1 plan.

IBEX Ltd's Chief Financial Officer, Taylor C Greenwald, sold 438 common shares at $29.13 each to cover tax withholding obligations related to restricted stock unit vesting.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 1,634 common shares at $29.13 each to cover tax withholding obligations related to restricted stock unit vesting.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, sold 3,831 common shares for $38.94 each, as disclosed in a recent SEC Form 4 filing.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, sold 255 common shares at $29.13 each to cover tax withholding obligations.

IBEX Chief Sales/Marketing Officer Julie K Casteel sold 295 common shares at $29.13 each to cover tax withholding obligations from restricted stock unit vesting.

IBEX Ltd's Chief Legal Officer, Christina Alice Trofimuk-O'Connor, sold 366 common shares at $29.13 each to cover tax withholding obligations related to restricted stock unit vesting.

IBEX Ltd's Chief Operating Officer, David Martin Afdahl, sold 403 common shares at $29.13 each to cover tax withholding obligations from restricted stock unit vesting.

IBEX Ltd's Chief Sales and CS Officer, Bruce Neil Dawson, sold 350 common shares at $29.13 each to cover tax withholding obligations related to restricted stock unit vesting.

IBEX Ltd's Chief People Officer, Paul Joseph Inson, reported the sale of 10,000 common shares at an average price of $30.0013, executed under a Rule 10b5-1 plan.

IBEX Ltd's Chief Executive Officer, Robert Thomas Dechant, sold a total of 5,000 common shares in early July 2025 through pre-scheduled transactions under a Rule 10b5-1 trading plan.

IBEX Ltd. Director Mohammedulla Khaishgi sold 5,000 common shares for approximately $28.007 per share on June 16, 2025, as part of a Rule 10b5-1 trading plan.

IBEX Ltd's Chief Executive Officer, Robert Thomas Dechant, reported the sale of 15,000 common shares on June 13, 2025, executed under a Rule 10b5-1 trading plan.

Mohammedulla Khaishgi, a Director at IBEX Ltd, has sold a total of 70,000 common shares over two days in June 2025, significantly reducing his direct beneficial ownership.

IBEX Ltd. Director Patrick McGinnis reported the sale of 220 common shares at $30 per share, reducing his direct beneficial ownership to 4,780 shares, executed under a Rule 10b5-1 plan.

Paul Joseph Inson, Chief People Officer of IBEX Ltd, has reported the sale of 3,690 common shares at a price of $28.59 per share, executed under a Rule 10b5-1 trading plan.

Bruce Neil Dawson, Chief Sales and CS Officer of IBEX Ltd., exercised stock options and sold shares on March 5, 2025.

IBEX Ltd CEO Robert Thomas Dechant exercised stock options and sold shares on February 26, 2025, resulting in a change in his beneficial ownership.

Director Mohammedulla Khaishgi sold 12,600 shares of Ibex Ltd on February 21, 2025, at an average price of $25.5744.

Director Mohammedulla Khaishgi reported selling common shares of Ibex Ltd in multiple transactions on February 19 and 20, 2025.

Director Mohammedulla Khaishgi sold shares of Ibex Ltd on February 18, 2025, according to a Form 4 filing.

Julie K. Casteel, Chief Sales/Marketing Officer of Ibex Ltd, exercised stock options and sold shares on February 14, 2025, resulting in changes to her beneficial ownership.

Director Karen Batungbacal acquired 5,000 restricted stock units in Ibex Ltd on February 14, 2025, according to a Form 4 filing.

Director Zhuang Mingzhe reports acquisition of 5,000 common shares and restricted stock units in Ibex Ltd.